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Objectives: We performed a 1-year prospective surveillance study on MRSA
colonization within the five NICUs of the metropolitan area of Palermo, Italy. The purpose
of the study was to assess epidemiology of MRSA in NICU from a network perspective.
Methods: Transfer of patients between NICUs during 2014 was traced based on
the annual hospital discharge records. In the period February 2014–January 2015,
in the NICU B, at the University teaching hospital, nasal swabs from all infants were
collected weekly, whereas in the other four NICUs (A, C, D, E) at 4 week-intervals of
time. MRSA isolates were submitted to antibiotic susceptibility testing, SCCmec typing,
PCR to detect lukS-PV and lukF-PV (lukS/F-PV ) genes and the gene encoding the toxic
shock syndrome toxin (TSST-1), multilocus variable number tandem repeat fingerprinting
(MLVF), and multilocus sequence typing (MLST).
Results: In the period under study, 587 nasal swabs were obtained from NICU B,
whereas 218, 180, 157, and 95 from NICUs A, C, D, and E, respectively. Two groups of
NICUs at high prevalence and low prevalence of MRSA colonization were recognized.
Overall, 113 isolates of MRSA were identified from 102 infants. Six MLVF types (A–F)
were detected, with type C being subdivided into five subtypes. Five sequence types
(STs) were found with ST22-IVa being the most frequent type in all NICUs. All the MRSA
molecular subtypes, except for ST1-IVa, were identified in NICU B.
Conclusions: Our findings support the need to approach surveillance and infection
control in NICU in a network perspective, prioritizing referral healthcare facilities.
Keywords: MRSA, active surveillance, network approach, molecular typing, NICu
INTRODUCTION
Methicillin resistant Staphylococcus aureus (MRSA) is a frequent causal agent of serious healthcare
related infections in neonatal intensive care units (NICUs; Carey and Long, 2010; Nelson and
Gallagher, 2012). Host factors, such as prematurity and immaturity of the immune system, and
some peculiarities of the NICU health care setting, such as prolonged hospitalization, exposure
to invasive procedures and high frequency of handling by healthcare workers (HCWs), are
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acknowledged to promote colonization and infection by MRSA
(Maraqa et al., 2011; Giuffrè et al., 2015). Overcrowding and
understaffing can ultimately play a key role in driving cross-
transmission and expand the MRSA reservoir (Andersen et al.,
2002). In high endemic countries, MRSA colonization and
infection are frequent in all healthcare facilities, but especially
in those providing tertiary care, where selection and spread or
influx of new clones of MRSA have higher probability to occur
(Donker et al., 2010). Indeed, on a wide geo-temporal scale the
emergence of major MRSA clones from previously circulating
methicillin susceptible S. aureus (MSSA) clones, by acquisition
of the methicillin resistance gene, has shaped the evolution of
MRSA. Conversely, in a regional or local perspective, between
patient transmission is believed to play a prominent role (Enright
et al., 2002; Donker et al., 2010).
In recent years, the referral of patients between healthcare
facilities has become the subject of many epidemiological studies
focusing the spread dynamics of nosocomial pathogens, with
special attention to multidrug resistant organisms (MDROs;
Donker et al., 2012; Ciccolini et al., 2013, 2014). Indeed, patient
and MDROs movement has been proven to stay behind many
inter-institutional outbreaks, whose size and impact largely
depend on the referral pattern of the site of the initial outbreak
(Donker et al., 2012; Ciccolini et al., 2013, 2014). MRSA, being
one of the most prevalent healthcare pathogens, has provided
most useful insights about the epidemiological consequences
of the inter-institutional patient transfer (Donker et al., 2012).
Availability of accurate and discriminative typing techniques has
undoubtedly facilitated these investigations (Azarian et al., 2015;
Nelson et al., 2015).
NICUs are currently being organized into neonatal networks
comprising a range of units providing different level and/or
subspecialty care in a given regional setting. We here describe the
findings of a 1-year prospective surveillance study on neonatal
MRSA colonization within the five NICUs of the metropolitan
area of Palermo, Italy. The purpose of the study was to provide
an update on epidemiology of MRSA in NICU from a network
perspective and, at the same time, to tentatively use MRSA
molecular fingerprinting to assess the epidemiological effects
of referral of patients within the NICUs in a high endemic
area.
MATERIALS AND METHODS
Setting and Design of the Study
Since February 10, 2014 a network surveillance study is
performed in five NICUs (NICUs A to E) in Palermo, Italy,
including the III level NICU (NICU B) of the teaching University
hospital AOUP “P. Giaccone.” This NICU is associated with
the regional reference center for genetic diseases and a neonatal
surgery unit. Consequently, the NICU admits a large proportion
of neonates with malformations or complex conditions requiring
surgical care (about 40%) as well as outborn infants transferred
from other hospitals (about 35%). The annual admissions to
this NICU average annually 250 infants. The metropolitan area
of Palermo, Italy, includes four additional NICUs. Their main
characteristics are summarized in Table 1.
TABLE 1 | Characteristics of the NICUs located in the metropolitan area of
Palermo, Italy.
NICU Intensive care Intermediate care Admissions Subspecialty
room cot room cot in 2014 care
spaces (nr) spaces (nr)
A 10 14 429 Neurosurgery,
Retinopathy of
prematurity
B 8 8 256 Genetic
diseases,
Neonatal surgery
C 8 8 371 Perinatal
hypoxic-
ischemic
encephalopathy
D 6 12 413 –
E 6 0 183 –
Transfer of patients between NICUs was traced by
quantifying their movements based on the annual hospital
discharge records deposited at the Regional Health Service
Statistical Office. Only the first transfer was counted for each
patient.
Active Surveillance Program and Case
Identification
In NICU B a surveillance program on MRSA colonization is
in place since 2009 by universal nasal sampling (Giuffrè et al.,
2015). Nasal swabs are collected on a weekly basis (eachMonday)
from all infants staying in NICU, regardless of their interval
of time since admission. In NICUs A, C, D, and E an active
surveillance program was initiated in February 2014. Nasal swabs
were similarly collected the same day from all infants, but at
4 week-intervals of time. For the purposes of this study, each
4-week interval was defined as a month.
Inclusion criteria for all patients were admission between
February 10, 2014 and January 11, 2015 (conventionally defined
as a year), hospitalization for at least 48 h, and collection of at
least one nasal swab. Colonization was defined as the isolation of
MRSA from anterior nares without evidence of infection.
Staff training regarding active surveillance and infection
control measures took place at the time of program
implementation. Reports of the active surveillance program
findings were regularly sent to the NICU staff each month.
Patients with MRSA colonization or infection were cohorted,
under standard contact precautions, but without dedicated
personnel due to the staff shortage. No decolonization strategies
were employed. Screening of HCWs and environmental
monitoring for MRSA were not carried out.
The study protocol and data handling were approved by the
ethical committee of the teaching University hospital AOUP “P.
Giaccone,” Palermo, Italy. The study was performed according
with the ethical standards established in the Declaration of
Helsinki. Written informed consent was obtained from the
parents or guardians of the neonates.
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Microbiological Procedures and Molecular
Typing
Surveillance specimens from the anterior nares of neonates
were obtained with cotton swabs, immediately transferred to
the laboratory and processed within 2 h. Nasal swabs were
incubated overnight in Brain Hearth Infusion (BHI) broth
(OXOID, Basingstoke, UK) and then plated onto mannitol
salt agar (OXOID), incubated in air at 35◦C and examined
at 24 and 48 h. Presumptive S. aureus isolates were identified
according to standard methods. MRSA isolates were searched
for by colony screening onto oxacillin agar (Mueller-Hinton
with oxacillin 6 mg/L) and confirmed by the cefoxitin disk
diffusion test and a mecA PCR (Bos¸gelmez-Tinaz et al.,
2006).
All isolates from MRSA colonized patients were submitted
to antibiotic susceptibility testing and genotyping. Antibacterial
drug susceptibility was routinely performed using the disk
diffusionmethod by determining the susceptibility of each isolate
to erythromycin, clindamycin, sulfamethoxazole-trimethoprim,
tetracycline, ciprofloxacin, gentamicin, tobramycin, linezolid,
rifampicin, vancomycin, and teicoplanin. S. aureus ATCC 25923
was used as the quality control strain. Results were interpreted
using the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) clinical breakpoints (http://www.eucast.org/
fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/).
Staphylococcal cassette chromosome (SCC) mec was typed
by the multiplex PCR method described by Milheiriço et al.
(2007). PCR was also performed with primers designed to
detect lukS-PV and lukF-PV (lukS/F-PV) genes, which encode
Panton-Valentine leukocidin (PVL), and the gene encoding the
toxic shock syndrome toxin (TSST-1), as described previously
(Mehrotra et al., 2000; Zhang et al., 2008).
Genotypic characterization of the MRSA isolates was
performed by multilocus variable number tandem repeat
fingerprinting (MLVF; Karynski et al., 2008). Gel images were
stored as TIFF files. Banding patterns were analyzed both visually
and by using Bionumerics version 5.10 (Applied Maths, Sint-
Martens-Latem, Belgium). The MLVF patterns consist of five to
seven bands. A difference of five or more bands between the
patterns was interpreted as a different type, and each type was
attributed with a capital letter. In the event of patterns differing
by less than five bands, they were categorized as subtypes of
a type, and each subtype identified by an additional numeric
suffix. Only indistinguishable patterns were attributed with the
same subtype. After a preliminary visual checking, the MLVF
patterns were analyzed using Bionumerics with the following
parameters: optimization 0.5% and position tolerance 1.25%.
Pairwise similarity coefficients were calculated using the Dice
formula, and dendrograms were created using the unweighted
pair-group method using geometric averages (UPGMA). The
similarity cutoff value between the MLVF patterns was set up at
the level of 70%.
Representative strains of all the different MLVF patterns were
analyzed by multilocus sequence typing (MLST). The MLST
allelic profiles and sequence types were assigned by submission
to the S. aureusMLST database (www.saureus.mlst.net).
Statistical Analysis
Monthly prevalence ofMRSA colonization was assessed using the
number of colonized infants at the time of nasal sampling for the
NICUs A, C, D, and E and the sum of the number of colonized
infants in the 4 days of sampling for NICU B. The number of
infants staying in NICU at the time of nasal sampling and the
total number of infants in the 4 days of sampling were used as
denominator, respectively, for NICUs A, C, D, and E and for
NICU B. Annual medians and interquartile ranges (IQRs) were
also estimated.
RESULTS
The number of admissions in the five NICUs under study
in the year 2014 is shown in Table 1. The structure of the
NICU referral network and the movements between NICUs
are schematically represented in Figure 1. Within this network,
NICU B exhibits the highest degree of connectivity, whereas
NICUs A and C assume an intermediate position and NICUs
D and E work as referring units only. The patient flow through
the network was thus prominently directed toward NICU B,
and to a lower extent toward NICUs A and C, both providing
specific subspecialty care. Because only the first transfer was
considered, but infants with complex conditions and prolonged
NICU stays can move through the NICU network several
times with different directionality, the referral pattern could
be substantially denser compared with the number of shared
patients.
FIGURE 1 | Diagrammatic representation of the NICU referral network
in the metropolitan area of Palermo, Italy, in 2014. The thickness of the
arrows is roughly proportional to the number of infants (in the squares) who
were referred between NICUs. Different colors indicate the directionality,
identifying the referring NICU.
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In the period under study, 587 nasal swabs were obtained
from NICU B, whereas 218, 180, 157, and 95 were obtained from
NICUs A, C, D, and E, respectively. The median prevalence of
MRSA colonization in the five NICUs in the interval of time
under consideration is illustrated in Figure 2. Two groups of
NICUs, high prevalence (D and E) and low prevalence (A, B, and
C), could be recognized.
During the period of surveillance, the MRSA colonization
prevalence substantially differed between NICUs and fluctuated
widely within each NICU (Figure 3). A general decreasing trend
was observed through all NICUs except for NICU A, which
consistently exhibited the lowest prevalence during the entire
period, except for the last 2 months.
Infection Control and Prevention Policies
A strengthening of the routine infection control policies was
adopted in all NICUs. They included: a revision of the invasive
devices management, adoption of contact precautions and
cohorting of infants colonized or infected by MRSA, use of
dedicated equipment and intensified environmental sanitation.
FIGURE 2 | Boxes and whiskers representation of the annual average
prevalence of MRSA colonization in the five NICUs under study,
Palermo, Italy, 2014. The median is shown by the dark horizontal line. The
25th and 75th percentiles comprise the boxes; whiskers extend to the
minimum and maximum values.
FIGURE 3 | Monthly prevalence of MRSA colonization in the NICUs
under surveillance, Palermo, Italy, 2014. In August, the active surveillance
culture (ACS) program in the NICUs A, C, D and E was interrupted.*Month is a
4-week interval of time.
Cleaning policies included post-discharge cot terminal cleaning
in the disinfection room, irrespective of the MRSA carriage
status of the occupant. Moreover, attention was dedicated to
prevent overcrowding and relative understaffing and minimize
length of hospital stay. No neonates were treated with mupirocin
for decolonization. MRSA screening of HCWs was not carried
out in any NICU. Cyclic training sessions of the NICUs staff
were planned. Inter-NICU communication regarding MRSA
colonization and infection and individual unit’s management
of shared infants was implemented. Infection prevention and
control was identified as an audit of importance for all the NICUs
and supportive for the network as a whole in regard to transfers
and patient pathways and good practice.
Strain Characterization
During the period under study, a total of 113 isolates of
MRSA were identified from 102 infants. Their antibacterial drug
resistance patterns and molecular epidemiological characteristics
are summarized in Table 2.
TABLE 2 | Antimicrobial drug resistance patterns and molecular types of
the MRSA isolates identified from infants staying in the five NICUs of
Palermo, Italy, 2014.
NICU ST/SCCmec MLVF Resistance nr. isolates nr. patients
type/subtype* pattern
A 1/IVa F TE 1 1
22/IVa C1 Susceptible 6 6
22/IVa C2 Susceptible 1 1
22/IVa C3 TE 1 1
B 5/IVg A GN 3 2
22/IVa C1 Susceptible 21 15
22/IVa C2 Susceptible 1 1
22/IVa C2 TE 2 2
22/IVa C3 Susceptible 1 1
80/IVc B TE 2 2
217/IVh E Susceptible 1 1
C 22/IVa C1 Susceptible 5 5
22/IVa C2 Susceptible 7 7
D 5/IVg A GN 10 10
22/IVa C1 Susceptible 6 6
22/IVa C2 Susceptible 3 3
22/IVa C2 TE 12 11
22/IVa C4 Susceptible 1 1
22/IVa C5 Susceptible 1 1
217/IVh E Susceptible 4 4
E 1/IVa D TE 3 1
22/IVa C1 Susceptible 6 5
22/IVa C2 Susceptible 16 16
ST, sequence type; SCCmec, Staphylococcal Cassette Chromosome mec; MLVF,
Multiple Locus Variable Number of Tandem Repeat Fingerprinting; TE, tetracycline; GN,
gentamicin* MLVF types are identified by capital letters and subtypes by capital letters
followed by Arabic numbers.
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Seventy-nine of 113 isolates (69.9%) were fully susceptible
to the panel of antimicrobial drugs tested. Twenty-one isolates
(18.6%) proved to be resistant to tetracycline and 13 (11.5%) to
gentamicin. Six MLVF types named A to F were identified, with
type C being subdivided into five different subtypes (Figure 4).
Type C accounted for 90 isolates (79.6%) and subtype C1 for 44
out of 90 isolates (48.9%). Overall, five STs were identified. ST22-
IVa was themost frequent type and proved to be invariably linked
with theMLVF type C. A close relatedness was generally apparent
betweenMLVF types and STs, except for the four ST1-IVa isolates
which were attributed with two different MLVF types. Moreover,
resistance to gentamicin was strictly associated with the ST5-
IVg, MLVF type A isolates, whereas resistance to tetracycline was
more erratic, being exhibited by all ST1-IVa and ST80-IV isolates
and some ST22-IVa–MLVF subtypes C2 and C3 isolates.
All ST22-IVa isolates were tst1-positive. The two ST80-
IVc isolates tested positive for PVL and negative for TSST-1
genes. All the remaining isolates were negative for both gene
sequences.
Colonization Cases in the Five NICUs
Based Upon MRSA Typing
In all NICUS infants were detected who tested positive for ST22-
IVa subtypes C1 and C2. MRSA isolates characterized as ST22-
IVa, subtype MLVF C1 and fully susceptible were predominant
in all NICUs, except NICU D. Conversely, MRSA isolates ST22-
IVa, subtype MLVF C2, and tetracycline resistant appeared to
be endemic in NICU D, being carried by 11 different neonates
during the surveillance period. A further interesting feature was
the detection of gentamicin resistant MRSA isolates ST5-IVg
with an apparently endemic pattern in NICU D, but also as a
sporadic finding inNICUB. Four infants staying inNICUDwere
colonized by a ST217-IVh MRSA strain which was also found
in one patient in NICU B. It is noteworthy the detection of two
neonates in NICU B carrying a ST80-IVc strain harboring genes
for PVL. The index case was an infant born to Tunisian parents.
DISCUSSION
We previously reported about MRSA colonization in the III
level NICU of the University Hospital of Palermo, Italy, where
a proportion as high as 22.8% of the admitted infants had
a nasal surveillance culture growing MRSA during the 4-year
period June 2009–June 2013 (Giuffrè et al., 2015). The prominent
presence of a strain characterized as tst1 positive, UK-EMRSA-
15/“Middle Eastern Variant,” which had been prior documented,
was confirmed (Geraci et al., 2014a). The same clone was also
detected in eight out of ten MRSA positive healthy preschool
children during a survey conducted in 2013 on 500 children
attending themunicipal daycare centers in the same town (Geraci
et al., 2014b).
Here we performed a surveillance prospective study onMRSA
colonization in NICUwith a network approach, targeting the five
NICUs located in the metropolitan area of Palermo, Italy, and
connected via the referred patients. Due to its endemicity in our
geographic setting, its clonal heterogeneity and the availability
of reliable and discriminative typing technique, MRSA is a
microrganism especially suited to trace movements between
community and NICUs and between different NICUs.
Some interesting findings can be emphasized. The first is the
evidence of different prevalences of MRSA colonization among
NICUs, with those providing subspecialty care showing lower
rates compared with those that do not. This can be speculatively
attributed to more stringent infection control practices in the
first ones, driven by the need to safely deliver sophisticated care
practices to fragile neonates. It should be also considered that
NICU D, the MRSA top-prevalent NICU, is associated with the
higher volume of births per annum in the maternity ward. In
an endemic setting, such as ours, where MRSA is spreading in
both healthcare facilities and community, this peculiar feature
could have favored the influx of MRSA strains into the NICU
(Jimenez-Truque et al., 2012; Lazenby et al., 2012). It is also
noteworthy that the referral III level NICU B had comparatively
low prevalences through the entire period of observation. In this
FIGURE 4 | Multilocus variable number tandem repeat fingerprinting (MLVF) patterns identified in the study. Lanes: MW, 100 bp DNA ladder; 1 to 10,
MLVF patterns A, B, C1, C2, C3, C4, C5, D, E, F.
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NICU weekly ASCs, which are routinely carried out since 2009,
are integrated into amultifaceted infection control program. This
has been previously proved to be associated to a containment
of MRSA cross-transmission and could likely explain the better
performance of NICU B (Giuffrè et al., 2015).
The second significant epidemiological feature is the further
evidence of the major role in our geographic setting of the
tst1 positive, UK-EMRSA-15/“Middle Eastern Variant” strain,
known as the “Gaza strain” (Biber et al., 2012; Al Laham et al.,
2015). Cross-transmission has likely contributed to the NICU
clusters of patients carrying isolates belonging to the different
MLVF subtypes. It is also interesting to observe that, except
for the sporadic C4 and C5 subtypes, the three most prevalent
subtypes, C1, C2, and C3, were all detected in NICU B. Because
of the documented presence of such a strain in the community,
its apparent endemicity can be interpreted as the result of an
import from the community or a trade within NICUs via referred
patients or both. Unfortunately, the design of this study does
not allow for an unambiguous answer. Nevertheless, in our
experience, MLVF confirmed to be a quick and easy method
to differentiate MRSA isolates within the CC22 complex. High
discriminatory power coupled with simplicity and low costs
make MLVF especially suitable to trace transmission routes and
investigate MRSA local epidemiology (Karynski et al., 2008).
Of further interest are the cluster of gentamicin resistant ST5-
IVg and the smaller cluster of ST217-IVh isolates, both occurring
in NICU D. CC5-MRSA-IV strains, colloquially described as
the “Paediatric Clone” have gained pandemic diffusion and
significant clinical relevance (Enright et al., 2002). Conversely,
ST217, a single-locus variant of EMRSA-15 within the CC22,
has been infrequently reported in literature, and once only in
Italy from the nasal swabs of a 5-year-old boy and his parents
(Vignaroli et al., 2014). Recently, emergence of this clone in the
community has been reported in India (Bouchiat et al., 2015).
Both these MRSA clones proved to be present with a limited
number of isolates in NICU B, as the result of a possible spillover
into this referral NICU.
Finally, two isolates of PVL positive, “European clone” ST80-
IVc were detected from two neonates in NICU B, with the
index case being a Tunisian children. Only a secondary case
was recorded due to the prompt alert to the NICU staff and the
infection control measures being routinely in place.
ST80/IV has consistently been recognized as the predominant
PVL-positive MRSA clone in North African and Middle East
countries (Harastani and Tokajian, 2014). In some European
countries ST80-MRSA has been sporadically detected and in
many cases associated with travel histories in Mediterranean
and Middle East countries (Harastani and Tokajian, 2014). A
recent study has provided solid evidence that the clonal spread of
MRSA ST80-IV has been boosted by the increased transnational
movements (Stegger et al., 2014).
The epidemiological snapshot ofMRSA distribution in the five
NICUs underlines the presence of all MRSA types and subtypes,
except for those at lowest prevalence, such as ST1 and ST22
MLVF subtypes C4 and C5, in the referral NICU B as a likely
consequence of its more dense referral pattern with the other
NICUs.
This study has some limitations. The ASC program was
not identical in all NICUs, with only infants in NICU B
being sampled weekly. Consequently, the results are not quite
comparable both in terms of prevalences and representativeness
of MRSA isolates. Indeed, the prevalence calculated in NICUs
with a low cot space number could have been easily misestimated
by amonthly point-prevalencemeasure. Conversely, themonthly
prevalences of NICU B were more solid and, due to the more
frequent sampling, all MRSA types/subtypes, including those
with low prevalence, had a higher probability of detection.
Moreover, movements of infants within NICUs were not traced
at the individual level, which could have made it possible to
incontestably confirm the trade of MRSA isolates within the
NICU network.
In accordance with the purpose of the study, we performed a
preliminary study to describe the epidemiology of MRSA in the
NICU network of a large metropolitan area, previously known to
be high-endemic. At the same time we tried to palpably depict the
connection pattern withinNICUs and its epidemiological impact,
using the consolidated molecular epidemiological markers of
MRSA. Our findings support the need to approach surveillance
and infection control in a network perspective, prioritizing
referral healthcare facilities. Further studies are necessary to
consolidate our results.
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